Organización Médica de Investigación (OMI)

Uruguay 725 PB , Buenos Aires, CP: 1015

Select an option

I am a doctor

I am a sponsor

Our team

Medical staff

Ana Malvar

Daniel Politis

Margarita Alfie

Open studies

Breast Cancer

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer - TROPION-Breast05 - AstraZenecaSee more

A Study of DB-1303/BNT323 vs Investigator's Choice Chemotherapy in HER2-Low, Hormone Receptor Positive Metastatic Breast Cancer (DYNASTY-Breast02) - DYNASTY-Breast02 - BioNTech SESee more

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence - ELEGANT - Stemline Therapeutics, Inc.See more

Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease - FourLight-3 - PfizerSee more

Alzheimer disease

A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4) - ADEPT-4 - Karuna TherapeuticsSee more

Glomerulonephritis

A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB - ACTION3 - Dimerix Bioscience Pty LtdSee more

Lupus

Phase 3 Study of Anifrolumab in Adult Patients With Active Proliferative Lupus Nephritis - IRIS - AstraZenecaSee more